Abstract

Introduction: Despite improved therapies and management, patients with systemic lupus erythematosus (SLE) still have increased risks of cerebrovascular and cardiovascular disease. High-frequency ultrasound (US) provides an opportunity to distinguish atherosclerosis from inflammation in the vessels. We hypothesized that an extended US protocol may add information regarding vascular affection in SLE.Methods: Sixty patients (52 women, 8 men; mean age 43.2 ± 11.3 years) with SLE characterized by either lupus nephritis (LN; n = 20), antiphospholipid syndrome (APS; n = 20), or skin and joint involvement (n = 20) as well as matched healthy controls (n = 60) were included. Intima-media thickness (IMT), assessment of vessel walls, and plaque occurrence were recorded using high-frequency US (GE Logic E9) in common carotid, internal carotid, brachiocephalic, subclavian, axillary, common femoral, and proximal superficial femoral arteries as well as in the aortic arch.Results: For the entire SLE group, IMT was increased in the internal carotid artery (0.52 ± 0.17 vs. 0.45 ± 0.09 mm, p = 0.004), the common femoral artery (0.57 ± 0.23 vs. 0.49 ± 0.11 mm, p < 0.01), the subclavian artery (0.58 ± 0.19 vs. 0.53 ± 0.13 mm, p = 0.02), and the aortic arch (1.21 ± 0.63 vs. 0.98 ± 0.25 mm, p = 0.002) compared to controls. These differences were primarily observed in the APS and LN groups compared to controls. Vessels with increased IMT ≥0.9 mm had a smooth, medium echogenic appearance in areas free of atherosclerotic plaques. Atherosclerotic plaques were detected in 15/60 patients (25%) as compared to 2/60 of the controls (3%). Plaques were predominantly (67%) located in the carotid bifurcation. Multivariate analysis revealed influence of age on IMT in all vessel areas. Furthermore, in the common femoral artery, sagittal abdominal diameter, diastolic blood pressure, and cholesterol all showed association with increased IMT. In the internal carotid artery, male sex and presence of Raynaud phenomenon influenced IMT.Conclusion: Among SLE patients without presence of plaques, an extended US protocol revealed increased wall thickness with predominantly medium echogenic appearance highlighting possibly inflammation or early atherosclerosis. The appearance of vessel walls has not previously been studied in detail. An increased number of plaques were found in SLE compared to age- and sex-matched healthy controls. We found similar risk factors for increased IMT and occurrence of plaques, possibly indicating atherosclerotic mechanisms rather than inflammation.

Highlights

  • Despite improved therapies and management, patients with systemic lupus erythematosus (SLE) still have increased risks of cerebrovascular and cardiovascular disease

  • In relation to Systemic lupus erythematosus (SLE) phenotypes, intima-media thickness (IMT) was still increased in the Antiphospholipid syndrome (APS) group compared to controls in common femoral artery (CFA) (p = 0.006), in the aortic arch (p < 0.001) and in internal carotid artery (ICA) (p = 0.01)

  • In this study of well-characterized SLE patients, the great majority with clinically inactive disease, thicker IMT detected with US was observed in ICA, CFA, subclavian artery (SCA), and the aortic arch compared to healthy controls, whereas IMT in common carotid artery (CCA) did not differ

Read more

Summary

Introduction

Despite improved therapies and management, patients with systemic lupus erythematosus (SLE) still have increased risks of cerebrovascular and cardiovascular disease. Age at examination (years) Female gender, n (%) Duration of SLE (years) SDI SLEDAI-2K Serologically active clinically quiescent SLE, n (%) Traditional risk factors and laboratory data Body mass index (BMI) (kg/m2) Waist circumference (cm) Sagittal abdominal diameter (cm) Ever smoker (former or current), n (%) Systolic blood pressure (mm Hg) Diastolic blood pressure (mm Hg) Diabetes mellitus, n (%) Raynaud’s phenomenon, n (%) Estimated glomerular filtration rate (mL/min/1,73 m2) Total cholesterol (mmol/L) High-density lipoprotein (HDL) (mmol/L) Low-density lipoprotein (LDL) (mmol/L) Triglycerides (TG) (mmol/L) High-sensitivity CRP (mg/L) Anti-dsDNA (IU/mL) Complement protein 3 (g/L) Complement protein 4 (g/L) Medical treatment, ongoing Antimalarial agents, n (%) Antihypertensives, n (%) Beta-blockers, n (%) ARB/ACE inhibitors, n (%) Other antihypertensives, n (%) Glucocorticoid therapy n (%) Mean daily Prednisolone dose (mg) Warfarin therapy, n (%) Antiplatelet therapy, n (%) Statin therapy n (%) DMARD therapy, n (%) Mycophenolate mofetil, n (%) Methotrexate, n (%) Azathioprine, n (%) Sirolimus, n (%) Dehydroepiandrosterone, n (%) Biologics, n (%) Bortezomib, n (%) Rituximab, n (%) Belimumab, n (%) 29 [48].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call